Learn about the immune system and immune checkpoint targets, as well as everything the oncology AP needs to know about managing immune-related adverse events.

Clinical Advances and Case Studies in Immune Checkpoint Inhibitors in Oncology

Immunotherapy has transformed the way oncology advanced practitioners care for patients with cancer. In this activity, get a comprehensive overview of the immune system, including immune checkpoint targets and their mechanisms of action, and learn about how to manage a wide range of immune-related adverse events through case studies centered around patients with non–small cell lung cancer, melanoma, and other malignancies.

This activity is supported by independent educational grants from AstraZeneca and Bristol-Myers Squibb.

Error loading Partial View script (file: ~/Views/MacroPartials/JADPRO CE Faculty.cshtml)
Error loading Partial View script (file: ~/Views/MacroPartials/JADPRO CE Topic Items.cshtml)

These CME/CE/CPE certified activities are jointly provided by

JADPRO CE Logo Harborside Press Logo APSHO Logo Annenberg Logo
Copyright © 2010-2022 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.